Article

WaveLight unveils new generation microkeratome

WaveLight today raised the curtain on its fine-tuned, new generation microkeratome, RONDO.

WaveLight today raised the curtain on its fine-tuned, new generation microkeratome, RONDO.

Although the microkeratome had been previously presented, the final adjustments have now been made to the firm's microkeratome and CEO Max Reindl and Head of the Product Management group, Mario Klafke, took pleasure in unveiling the new device to the ophthalmic community today.

According to Mr Klafke, the majority of product testing was dedicated to patient safety and user-friendliness. As a result, WaveLight now believes it has achieved its goal to develop a state-of-the-art microkeratome that meets high quality standards for results and patient safety.

Some of the features of RONDO include the special blade shooter, which allows easy and safe blade handling, thus preventing contamination and minimising the risk of injuries. Meanwhile, the system's advanced blade positioning capabilities, ensures the blade's position is consistently fixed, resulting in predictable flap thickness, and the three sizes of cutting heads allow surgeons to vary flap thicknesses (100, 130 and 150 µm).

Additional features include the elevated suction ring with active vacuum adjustment, integrated aspiration pump for an aspirating speculum, variable hinge position and size, pre-assembled head for quick application onto the eye and low vacuum (400 to 620 mmHg) to prevent raised intraocular pressure.

RONDO's console, meanwhile, allows surgeons to accurately document every single treatment performed with the device, thus allowing meticulous record keeping and quick data retrieval when necessary.

"Importantly, the flap thickness is stable with RONDO; it has a low standard deviation, which ensures uniformity and precision. It is light, smooth, sterile and sharp, thus yielding a smooth residual stromal bed," said Mr Klafke.

According to the manufacturers, the price of the console and blades makes RONDO comparable, in terms of price, to other currently marketed microkeratomes, however, it believes that the clinical results witnessed so far make RONDO the superior choice of microkeratome.

"Based on the feedback we have received so far, surgeons have been surprised by the constant flap thickness and the quality of the stromal bed achieved with RONDO," enthused Mr Klafke.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
© 2025 MJH Life Sciences

All rights reserved.